These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2543000)

  • 21. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
    Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing hemodynamic responses to atrial natriuretic factor in two models of hypertension.
    Volpe M; Sosa RE; Müller FB; Camargo MJ; Glorioso N; Laragh JH; Maack T; Atlas SA
    Am J Physiol; 1986 May; 250(5 Pt 2):H871-8. PubMed ID: 2939731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered vascular beta adrenoceptor-mediated relaxation in deoxycorticosterone-salt hypertensive rats.
    Fujimoto S; Dohi Y; Aoki K; Matsuda T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):716-23. PubMed ID: 2831351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic and cardiovascular effects of infusions of low doses of isoprenaline in man.
    Mansell PI; Fellows IW; Birmingham AT; Macdonald IA
    Clin Sci (Lond); 1988 Sep; 75(3):285-91. PubMed ID: 3046824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of β-adrenoceptor-mediated relaxation signals in isolated pulmonary artery of Dahl salt-sensitive hypertensive and normotensive rats.
    Ford CA; Mahajan P; Tabrizchi R
    Auton Autacoid Pharmacol; 2011; 31(1-2):1-12. PubMed ID: 20955515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced presynaptic beta 2-adrenergic facilitatory mechanism in conscious deoxycorticosterone acetate-salt hypertensive rats.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens Suppl; 1991 Dec; 9(6):S68-9. PubMed ID: 1668014
    [No Abstract]   [Full Text] [Related]  

  • 29. Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension.
    Li L; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Mar; 41(3 Pt 2):663-8. PubMed ID: 12623976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperresponsiveness of sympathoadrenal system in conscious DOCA-NaCl and SHR rats in response to acute hemorrhagic hypotension.
    Drolet G; de Champlain J
    Clin Invest Med; 1992 Aug; 15(4):360-70. PubMed ID: 1516293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary excretion of digoxin-like factor (DLF) and ADH during DOCA-salt and Goldblatt 2 kidney-1 clip hypertension development.
    Vargas F; Casanova I; Haro JM; Luna JD; Garcia del Rio C
    Horm Metab Res; 1990 Jun; 22(6):352-5. PubMed ID: 2199365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the isoprenaline-induced renin release by bilateral vagotomy is mediated by vasopressin.
    Knepel W; Meyer DK
    Endokrinologie; 1981 Jul; 77(3):325-32. PubMed ID: 7023920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic and regional haemodynamic responses to isoprenaline in conscious renal hypertensive rabbits.
    van Boom M; Saxena PR
    Clin Exp Pharmacol Physiol; 1981; 8(3):227-39. PubMed ID: 7249410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen metabolite 2-methoxyestradiol prevents hypertension in deoxycorticosterone acetate-salt rats.
    Yuan W; Yu Y; Li J; Singh P; Li D; Gui Y; Zheng XL
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):17-22. PubMed ID: 23229845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension.
    Naitoh M; Suzuki H; Arakawa K; Matsumoto A; Ichihara A; Matsuda H; Kubota E; Murakami M; Nakamoto H; Saruta T
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H679-87. PubMed ID: 9124424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renovascular beta adrenergic hypersensitivity and hyperinsulinemia in rats with dietary-induced obesity.
    Buñag RD; Tomita T; Krizsan D
    J Pharmacol Exp Ther; 1990 Oct; 255(1):325-32. PubMed ID: 2170625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some factors modifying the insulinotropic and cardiovascular effects of isoprenaline in the rat.
    Twaij HA; Furman BL
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):109-18. PubMed ID: 7039543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential venous effects of isoprenaline in conscious rats.
    Abdelrahman A; Pang CC
    Eur J Pharmacol; 1990 Nov; 190(3):321-7. PubMed ID: 2272370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of circulating renin in drinking in response to isoprenaline.
    Atkinson J; Kaesermann HP; Lambelet J; Peters G; Peters-Haefeli L
    J Physiol; 1979 Jun; 291():61-73. PubMed ID: 480253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.